"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."
Sir John Bell
- Home
- Fundraising
- About Us
- About Leukaemia
- Patient Stories
- The Tour 21
- London 2 Paris 2021
Menu
Fundraising
About Us
About Leukaemia
Patient Stories
The Tour 21
London 2 Paris 2021
- News
- Our TAP Centres and Nurses
- Where Your Money Goes
- What Our Nurses Do
- Corporate Partnerships
- Deutsche Bank Partnership
- The Impact Of One Day
- A Message From Cure Leukaemia co-founder Professor Charlie Craddock CBE
- Deutsche Bank's £2m Positive Impact
- Patient Stories
- Working Together - Events To Excite And Engage
- Let's Get Social
- Well-Known Figures Show Their Support For Cure Leukaemia
- Publications
- Privacy Policy
- Join The #CLFamily
- Sustainability Policy
Join The #CLFamily
.jpg)
In line with the new GDPR legislation we are updating how we store and handle your data.
By taking a few seconds to fill in the form below you are agreeing to receive emails from time-to-time from Cure Leukaemia regarding our extensive range of events and all the latest news from the charity.
If you do not fill in this form you will no longer receive emails from Cure Leukaemia after Friday May 25th 2018.
We hope you are keen to stay in touch with us and continue being an integral part of the #CLFamily. If you do, please click the button below to subscribe:
By clicking 'Subscribe' you agree to Cure Leukaemia using your personal data in accordance with our Privacy Policy.
You will receive a confirmation email when you subscribe. If you do not receive this please check your junk email folder or email info@cureleukaemia.co.uk.